95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.60%
Revenue growth 1.25-1.5x FSM's 4.58%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
2.05%
Gross profit growth above 1.5x FSM's 0.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
2.39%
Positive EBIT growth while FSM is negative. John Neff might see a substantial edge in operational management.
2.39%
Positive operating income growth while FSM is negative. John Neff might view this as a competitive edge in operations.
367.01%
Positive net income growth while FSM is negative. John Neff might see a big relative performance advantage.
380.00%
Positive EPS growth while FSM is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
380.00%
Positive diluted EPS growth while FSM is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.10%
Share count expansion well above FSM's 0.03%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.13%
Diluted share count expanding well above FSM's 0.27%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
7.87%
OCF growth at 75-90% of FSM's 9.01%. Bill Ackman would demand better working capital management or cost discipline.
-483.01%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
115.86%
10Y revenue/share CAGR under 50% of FSM's 410.53%. Michael Burry would suspect a lasting competitive disadvantage.
1.89%
5Y revenue/share CAGR under 50% of FSM's 92.05%. Michael Burry would suspect a significant competitive gap or product weakness.
17.79%
3Y revenue/share CAGR under 50% of FSM's 53.08%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
90.20%
10Y OCF/share CAGR under 50% of FSM's 188.76%. Michael Burry would worry about a persistent underperformance in cash creation.
-13.59%
Negative 5Y OCF/share CAGR while FSM is at 684.35%. Joel Greenblatt would question the firm’s operational model or cost structure.
12.80%
3Y OCF/share CAGR under 50% of FSM's 246.54%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
590.04%
Net income/share CAGR above 1.5x FSM's 153.98% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
258.13%
5Y net income/share CAGR 1.25-1.5x FSM's 182.78%. Bruce Berkowitz would check if a better product mix or cost discipline explains the gap.
439.98%
Below 50% of FSM's 3716.57%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
227.59%
10Y equity/share CAGR 1.25-1.5x FSM's 189.73%. Bruce Berkowitz would see if strong ROE or conservative payout policy fosters faster book value growth.
30.26%
Below 50% of FSM's 77.26%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
6.84%
Below 50% of FSM's 71.72%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
-43.93%
Negative 5Y dividend/share CAGR while FSM stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
71.00%
3Y dividend/share CAGR of 71.00% while FSM is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
453.10%
AR growth well above FSM's 5.13%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
10.26%
Asset growth above 1.5x FSM's 1.93%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.16%
BV/share growth above 1.5x FSM's 2.28%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
44.27%
We have some new debt while FSM reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
28.15%
SG&A growth well above FSM's 16.61%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.